RecruitingNCT07395037

A Study of Ward Admissions for Haematuria

Ward AdmiSsion of Haematuria: an Observational mUlticentre sTudy

Sponsor

British Urology Researchers in Surgical Training

Enrollment

1,050 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Urothelial Carcinoma Bladder Cancer Renal Cancer Urologic Diseases Hematuria Hematuria; Benign

Summary

This multicenter, prospective observational study will evaluate national and international practice variations (if present) in the emergency management of patients admitted to hospital with haematuria, inform a consensus guideline for best practice and provide evidence to design an implementation study to optimise haematuria management pathway.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data on patients who are admitted to a hospital urology unit with blood in their urine (haematuria) as an emergency. The goal is to understand the causes, management, and outcomes of these admissions across multiple hospitals, which can help improve how this condition is treated in the future. This is an observational study — your care is not changed. **You may be eligible if...** - You are 16 years old or older - You were admitted to a participating urology unit as an emergency - Your primary or secondary reason for admission is blood in the urine (haematuria) **You may NOT be eligible if...** - You are under 16 years old - Your blood in the urine was caused by trauma from a urinary catheter insertion - Your hospital stay is less than 24 hours Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInpatient work-up and management

The study hypothesis is that there is significant international and national variation in the diagnostic workup and management of patients requiring admission to the hospital with haematuria. Increased length of stay and poor outcomes in terms of mortality and healthcare costs are associated with management practices. The CRF will collect datapoints on inpatient work-up and management.

Locations(1)

BURST

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07395037

Related Trials

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

NCT000268841 location

DESTINY-PANTUMOUR04

NCT0712400017 locations

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

NCT072417936 locations

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

NCT0741929521 locations

Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma at High-Risk Recurrence

NCT066827281 location